Clinical Trials Browser

Phase 2 × Psoriasis × abrocitinib × Clear all

NCT02201524 2016-10-05

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Phase 2 Terminated

59 enrolled 18 charts

Lymphoma, Follicular, Psoriasis, Plaque, Amyloid